China National Accord Medicines Corporation Ltd. logo

China National Accord Medicines Corporation Ltd. (200028)

Market Closed
11 Aug, 06:57
XSHE XSHE
12. 00
HKD
+0.06
+0.5025%
HKD
7.27B Market Cap
9.89 P/E Ratio
1.6% Div Yield
303,328 Volume
2.96 Eps
11.94 HKD
Previous Close
Add Transaction
Day Range
11.92 12.08
Year Range
11.5 12.81
Want to track 200028 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

China National Accord Medicines Corporation Ltd. (200028) Statistics

Valuation metrics

Market Cap 7.27B
Enterprise value 18.77B
Trailing P/E (ttm) 10.31
Forward P/E 4.54
PEG ratio 0.12
Price/Sales (ttm) 0.15
Price/Book (mrq) 0.59
Enterprise Value/Revenue 0.26
Enterprise Value/EBITDA 8.32

Overview

Shares outstanding 556.57M
Float 237.64M
Shares short -
% Held by insiders 0.03%
% Held by institutions 0.05%
Average volume (10 days) 146.74K
Average volume (90 days) 224.26K

Price summary

52-Week low 11.5
52-Week high 12.81
Beta 0.18
50-Day moving average 11.89
200-Day moving average 13.29

Dividends and splits

Forward annual dividend rate 1.6
Forward annual dividend yield 0.1163%
Trailing annual dividend rate 0.62
Trailing annual dividend yield 0.0303%
5-Year annual dividend yield 4.8%
Payout ratio 0.45
Dividend Date 26 Jun 2026
Ex-Dividend Date 24 Jun 2026
Last split factor 1:1
Last split Date 26 Jun 2026

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.02%
Operating margin 0.02%

Operational effectiveness

Return on assets 0.02%
Return on equity 0.06%

Income Statement

Revenue (ttm) 84.01B
Revenue per share (ttm) 131.95
Quarterly revenue growth (yoy) -0.03%
Gross profit (ttm) 8.91B
EBITDA 3.47B
Net income to common (ttm) 1.26B
Diluted EPS (ttm) 1.98
Quarterly earnings growth (yoy) -0.12%

Balance Sheet

Total cash (mrq) 8.99B
Total cash per share (mrq) 9.37
Total debt (mrq) 5.19B
Total Debt/Equity (mrq) 0.69
Current ratio (mrq) 1.56%
Book value per share (mrq) 39.64

Cash Flow

Cash flow statement 599.47M
Levered free cash flow (LFCF) 2.29B